Company profile for Stuart Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Stuart Therapeutics was founded to bring a fresh point of view to the development of therapies for difficult to treat ophthalmic diseases. Our team brings a wide variety of proven clinical, pharmaceutical R&D, operational and partnering skills to support our venture. Our core inventor group identified the promise of PolyCol and has established broad patent coverage to provide the company with an array of options for partnering...
Stuart Therapeutics was founded to bring a fresh point of view to the development of therapies for difficult to treat ophthalmic diseases. Our team brings a wide variety of proven clinical, pharmaceutical R&D, operational and partnering skills to support our venture. Our core inventor group identified the promise of PolyCol and has established broad patent coverage to provide the company with an array of options for partnering and internal development. The areas of medicine on which we are focused have affected all of the members of our team, either directly or indirectly.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
411 SE Osceola St. Suite 203 Stuart, FL 34994
Telephone
Telephone
(772) 678-7307
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/stuart-sees-dry-eye-disease-drug-fail-phase-3-test-plans-another-study

FIERCE PHARMA
25 Jun 2025

https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-initial-results-of-phase-iii-clinical-trial-for-st-100-vezocolmitide-ophthalmic-solution-a-novel-dry-eye-disease-candidate-302489203.html

PR NEWSWIRE
24 Jun 2025

https://www.contractpharma.com/contents/view_breaking-news/2024-07-25/stuart-therapeutics-taps-dr-lukas-scheibler-as-chief-science-technology-officer/?widget=listSection

CONTRACT PHARMA
25 Jul 2024

https://www.prnewswire.com/news-releases/stuart-therapeutics-inc-announces-key-addition-to-its-executive-team-302206966.html

PR NEWSWIRE
25 Jul 2024

https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-first-patient-first-visit-in-its-phase-3-clinical-trial-of-vezocolmitide-for-dry-eye-disease-302023987.html

PR NEWSWIRE
29 Dec 2023

https://www.prnewswire.com/news-releases/stuart-therapeutics-announces-exclusive-worldwide-license-agreement-with-glaukos-corporation-301961150.html

PR NEWSWIRE
18 Oct 2023

ABOUT THIS PAGE

Contact Stuart Therapeutics and get a quotation

Stuart Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Isosorbide Dinitrate bulk offered by Stuart Therapeutics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty